RxDoctor Payments Data

Stacey Tarvin

Pediatric Rheumatology · Indianapolis, INNPI 1639380769

Payments from drug & device makers

$567,669in general payments, 2019–2025

Across 57 payments — averaging $9959.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$230K
  • E.r. Squibb & Sons, L.L.C.$128K
  • UCB GmbH$85K
  • Pfizer$62K
  • AbbVie$40K
  • Genentech, Inc.$22K
$900in research payments, 2019–2025

Across 1 payment — averaging $900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$900

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen5$230,432
E.r. Squibb & Sons, L.L.C.11$127,997
UCB GmbH8$84,680
Pfizer22$62,465
AbbVie8$40,132
Genentech, Inc.3$21,963

How this compares

Too few pediatric rheumatology providers in Indianato place this figure against a meaningful peer group, so we don't.

Other pediatric rheumatology in Indianapolis

Where these figures come from

Is this you, or does something look wrong? →